Location: New York, NY
CIK: 0001009258 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value: $1.875B (83.0% shares, 17.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AVEXIS INC | 2,308,130 | $190M | 10.1% | — | — | COM | 05366U100 |
| — | HORIZON PHARMA PLC | 8,998,413 | $107M | 5.7% | — | — | SHS | G4617B105 |
| — | NXSTAGE MEDICAL INC | 3,833,330 | $96.1M | 5.1% | — | — | COM | 67072V103 |
| GILD | GILEAD SCIENCES INC | 938,515 | $66.43M | 3.5% | — | — | COM | 375558103 |
| — | HORIZON PHARMA INVT LTD | 74,100,000 | $64M | 3.4% | — | — | NOTE 2.500% 3/1 | 44052TAB7 |
| GILD | GILEAD SCIENCES INC | 750,000 | $53.09M | 2.8% | — | — | Call | 375558103 |
| — | MYLAN N V | 1,367,119 | $53.07M | 2.8% | — | — | SHS EURO | N59465109 |
| — | MALLINCKRODT PUB LTD CO | 1,178,605 | $52.81M | 2.8% | — | — | SHS | G5785G107 |
| MCK | MCKESSON CORP | 315,417 | $51.9M | 2.8% | — | — | COM | 58155Q103 |
| — | AERIE PHARMACEUTICALS INC | 961,147 | $50.51M | 2.7% | — | — | COM | 00771V108 |
| — | ISIS PHARMACEUTICALS INC DEL | 42,200,000 | $44.89M | 2.4% | — | — | NOTE 1.000%11/1 | 464337AJ3 |
| — | KEMPHARM INC | 75,000,000 | $44.25M | 2.4% | — | — | NOTE 5.500% 2/0 | 488445AB3 |
| — | AVADEL PHARMACEUTICALS PLC | 3,655,494 | $40.32M | 2.2% | — | — | SPONSORED ADR | 05337M104 |
| — | TRINITY BIOTECH INVT LTD | 48,000,000 | $38.43M | 2.0% | — | — | NOTE 4.000% 4/0 | 89643QAB4 |
| GKOS | GLAUKOS CORP | 894,551 | $37.1M | 2.0% | — | — | COM | 377322102 |
| — | GW PHARMACEUTICALS PLC | 359,983 | $36.09M | 1.9% | — | — | ADS | 36197T103 |
| — | ENDOLOGIX INC | 40,500,000 | $34.31M | 1.8% | — | — | NOTE 3.250%11/0 | 29266SAB2 |
| — | INTERSECT ENT INC | 1,189,577 | $33.25M | 1.8% | — | — | COM | 46071F103 |
| — | AUDENTES THERAPEUTICS INC | 1,729,268 | $33.08M | 1.8% | — | — | COM | 05070R104 |
| — | LANNET INC | 1,523,957 | $31.09M | 1.7% | — | — | COM | 516012101 |
| — | NEVRO CORP | 27,600,000 | $29.62M | 1.6% | — | — | NOTE 1.750% 6/0 | 64157FAA1 |
| EDIT | EDITAS MEDICINE INC | 1,709,400 | $28.68M | 1.5% | — | — | COM | 28106W103 |
| — | NEVRO CORP | 376,308 | $28.01M | 1.5% | — | — | COM | 64157F103 |
| — | DBV TECHNOLOGIES S A | 665,197 | $23.75M | 1.3% | — | — | SPONSORED ADR | 23306J101 |
| — | PORTOLA PHARMACEUTICALS INC | 419,000 | $23.54M | 1.3% | — | — | COM | 737010108 |
| — | INTERCEPT PHARMACEUTICALS IN | 22,500,000 | $21.98M | 1.2% | — | — | NOTE 3.250% 7/0 | 45845PAA6 |
| — | SELECTA BIOSCIENCES INC | 1,060,000 | $21.05M | 1.1% | — | — | COM | 816212104 |
| — | SYROS PHARMACEUTICALS INC | 1,268,945 | $20.42M | 1.1% | — | — | COM | 87184Q107 |
| — | LOXO ONCOLOGY INC | 251,167 | $20.14M | 1.1% | — | — | COM | 548862101 |
| — | AETNA INC NEW | 130,000 | $19.74M | 1.1% | — | — | COM | 00817Y108 |
| BCRX | BIOCRYST PHARMACEUTICALS | 3,499,202 | $19.46M | 1.0% | — | — | COM | 09058V103 |
| — | PATTERSON COMPANIES INC | 393,262 | $18.46M | 1.0% | — | — | COM | 703395103 |
| DXCM | DEXCOM INC | 247,841 | $18.13M | 1.0% | — | — | COM | 252131107 |
| — | FLUIDIGM CORP DEL | 27,715,000 | $17.22M | 0.9% | — | — | NOTE 2.750% 2/0 | 34385PAA6 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 945,710 | $15.91M | 0.8% | — | — | ORD SHS | G6855A103 |
| — | ADVANCED ACCELERATOR APPLIC | 392,904 | $15.34M | 0.8% | — | — | SPONSORED ADS | 00790T100 |
| GLPG | GALAPAGOS NV | 187,501 | $14.35M | 0.8% | — | — | SPON ADR | 36315X101 |
| ELV | ANTHEM INC | 75,182 | $14.14M | 0.8% | — | — | COM | 036752103 |
| WVE | WAVE LIFE SCIENCES LTD | 746,841 | $13.89M | 0.7% | — | — | SHS | Y95308105 |
| — | AAC HLDGS INC | 1,975,347 | $13.69M | 0.7% | — | — | COM | 000307108 |
| — | AEGERION PHARMACEUTICALS INC | 16,600,000 | $13.46M | 0.7% | — | — | NOTE 2.000% 8/1 | 00767EAB8 |
| — | RECRO PHARMA INC | 1,901,685 | $13.37M | 0.7% | — | — | COM | 75629F109 |
| ANAB | ANAPTYSBIO INC | 552,859 | $13.23M | 0.7% | — | — | COM | 032724106 |
| EHTH | EHEALTH INC | 690,348 | $12.98M | 0.7% | — | — | COM | 28238P109 |
| XNCR | XENCOR INC | 562,236 | $11.87M | 0.6% | — | — | COM | 98401F105 |
| CTMX | CYTOMX THERAPEUTICS INC | 756,822 | $11.73M | 0.6% | — | — | COM | 23284F105 |
| ASND | ASCENDIS PHARMA A S | 419,453 | $11.64M | 0.6% | — | — | SPONSORED ADR | 04351P101 |
| ARDX | ARDELYX INC | 2,279,780 | $11.63M | 0.6% | — | — | COM | 039697107 |
| AXGN | AXOGEN INC | 674,428 | $11.3M | 0.6% | — | — | COM | 05463X106 |
| ARGX | ARGENX SE | 509,022 | $10.8M | 0.6% | — | — | SPONSORED ADR | 04016X101 |
| — | NEOS THERAPEUTICS INC | 1,459,195 | $10.65M | 0.6% | — | — | COM | 64052L106 |
| MOH | MOLINA HEALTHCARE INC | 151,665 | $10.49M | 0.6% | — | — | COM | 60855R100 |
| — | BLUEPRINT MEDICINES CORP | 203,000 | $10.29M | 0.5% | — | — | COM | 09627Y109 |
| ACRS | ACLARIS THERAPEUTICS INC | 375,000 | $10.17M | 0.5% | — | — | COM | 00461U105 |
| — | EPIZYME INC | 662,369 | $10M | 0.5% | — | — | COM | 29428V104 |
| — | ALLSCRIPTS HEALTHCARE SOLUTN | 9,671,000 | $9.83M | 0.5% | — | — | NOTE 1.250% 7/0 | 01988PAD0 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,094,305 | $9.63M | 0.5% | — | — | COM | 800677106 |
| CNC | CENTENE CORP DEL | 119,000 | $9.506M | 0.5% | — | — | COM | 15135B101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 104,000 | $9.09M | 0.5% | — | — | Put | 74587V107 |
| — | STEADYMED LTD | 1,441,913 | $9.084M | 0.5% | — | — | SHS | M84920103 |
| — | NIVALIS THERAPEUTICS INC | 3,732,412 | $8.995M | 0.5% | — | — | COM | 65481J109 |
| — | INVUITY INC | 1,177,229 | $8.535M | 0.5% | — | — | COM NEW | 46187J205 |
| SEM | SELECT MED HLDGS CORP | 504,632 | $7.746M | 0.4% | — | — | COM | 81619Q105 |
| — | ARENA PHARMACEUTICALS INC | 416,729 | $7.03M | 0.4% | — | — | COM NEW | 040047607 |
| — | ALIMERA SCIENCES INC | 4,769,551 | $6.63M | 0.4% | — | — | COM | 016259103 |
| — | AXOVANT SCIENCES LTD | 239,180 | $5.547M | 0.3% | — | — | COM | G0750W104 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 216,761 | $5.419M | 0.3% | — | — | COM | G11196105 |
| — | MYOVANT SCIENCES LTD | 400,685 | $4.688M | 0.3% | — | — | COM | G637AM102 |
| — | SIERRA ONCOLOGY INC | 3,495,734 | $4.09M | 0.2% | — | — | COM | 82640U107 |
| MNKD | MANNKIND CORP | 2,702,403 | $3.81M | 0.2% | — | — | COM NEW | 56400P706 |
| — | FOAMIX PHARMACEUTICALS LTD | 817,435 | $3.793M | 0.2% | — | — | SHS | M46135105 |
| — | AKARI THERAPEUTICS PLC | 818,158 | $3.772M | 0.2% | — | — | SPONSORED ADR | 00972G108 |
| — | MYOKARDIA INC | 279,752 | $3.665M | 0.2% | — | — | COM | 62857M105 |
| — | BIOSCRIP INC | 1,327,966 | $3.605M | 0.2% | — | — | COM | 09069N108 |
| — | AGILE THERAPEUTICS INC | 955,109 | $3.582M | 0.2% | — | — | COM | 00847L100 |
| — | JOUNCE THERAPEUTICS INC | 247,872 | $3.478M | 0.2% | — | — | COM | 481116101 |
| — | KEMPHARM INC | 704,612 | $2.818M | 0.2% | — | — | COM | 488445107 |
| BCRX | BIOCRYST PHARMACEUTICALS | 500,000 | $2.78M | 0.1% | — | — | Call | 09058V103 |
| — | ARALEZ PHARMACEUTICALS INC | 1,644,583 | $2.22M | 0.1% | — | — | COM | 03852X100 |
| — | PROTEON THERAPEUTICS INC | 1,224,899 | $1.868M | 0.1% | — | — | COM | 74371L109 |
| — | OBALON THERAPEUTICS INC | 183,086 | $1.814M | 0.1% | — | — | COM | 67424L100 |
| — | RA PHARMACEUTICALS INC | 82,593 | $1.548M | 0.1% | — | — | COM | 74933V108 |
| VYGR | VOYAGER THERAPEUTICS INC | 117,647 | $1.054M | 0.1% | — | — | COM | 92915B106 |
| — | ESSA PHARMA INC | 1,416,230 | $779K | 0.0% | — | — | COM | 29668H104 |
| — | PROTEOSTASIS THERAPEUTICS IN | 17,251 | $81,000 | 0.0% | — | — | COM | 74373B109 |